Accretion Pharma Board Approves Key Financial and Structural Changes
Accretion Pharmaceuticals Ltd 路 Others (Uncategorized) 路 01 Sept 2026, 7:16 pm
Accretion Pharma Board Approves Key Financial and Structural Changes Accretion Pharmaceuticals' board, on 1st Sep'26, approved key proposals subject to shareholder consent. These include altering the MOA's object clause to expand business activities and raising borrowing limits under Section 180(1)(c). The board also approved enhancing limits for creating charges on assets under Section 180(1)(a). Additionally, proposals were passed for advancing loans/guarantees to related parties and exceeding prescribed limits for loans, guarantees, and investments. All approvals are contingent on a forthcoming postal ballot for shareholder ratification.
Original exchange filing (PDF)
More announcements from Accretion Pharmaceuticals Ltd
- Accretion Pharmaceuticals Limited has informed the Exchange about General Updates 路 16 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentation 路 03 Nov 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 31, 2026, titled "Company Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27 and Strong EBITDA Growth of 72.28%; EBITDA Margin Improves to 22.48%". 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the half year ended September 30, 2026. 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 31 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report. 路 12 Oct 2026
